Evidence against Ha-ras-1 involvement in sporadic and familial melanoma
- PMID: 2879249
- DOI: 10.1038/325073a0
Evidence against Ha-ras-1 involvement in sporadic and familial melanoma
Abstract
It was recently reported that different rare alleles at the Ha-ras-1 locus occurred at a significantly higher combined frequency in cancer patients than in an unaffected population. In particular, melanoma patients were reported to have a significantly higher frequency of such alleles. We have examined the frequency of rare Ha-ras-1 alleles in a large number of cases of sporadic melanoma. Our results indicate that the distribution of rare alleles in this population does not differ from that found in normal populations. Also, to test the hypothesis that a hereditary predisposition to melanoma could be inherited via an allele at the Ha-ras-1 locus, we examined the transmission of the segment of the short arm of chromosome 11 (11p) carrying the Ha-ras-1 locus in a number of families previously shown to exhibit a hereditary predisposition to melanoma and its precursor lesion, the dysplastic nevus syndrome (DNS). Our genetic linkage results thus obtained strongly exclude the association of a predisposition to melanoma or the precursor lesion with the inheritance of the Ha-ras-1 locus or the segment of chromosome 11 on which it is located. These results imply that hereditary predisposition to melanoma is associated with genes other than the Ha-ras-1 locus, contradicting the original suggestion of Krontiris et al., made on the basis of either an inadequate sample size or other misleading experimental factors.
Similar articles
-
c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.Oncogene Res. 1988 Feb;2(3):245-50. Oncogene Res. 1988. PMID: 2897104
-
Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds.Br J Cancer. 1986 Nov;54(5):787-90. doi: 10.1038/bjc.1986.241. Br J Cancer. 1986. PMID: 2879551 Free PMC article.
-
Ha-ras hypervariable alleles in myelodysplasia.Nature. 1986 May 1-7;321(6065):84-5. doi: 10.1038/321084a0. Nature. 1986. PMID: 3010134
-
[Genetic polymorphism and susceptibility to cancer].Nouv Rev Fr Hematol (1978). 1988;30(1-2):39-43. Nouv Rev Fr Hematol (1978). 1988. PMID: 2898751 Review. French.
-
Recent advances in the molecular genetics of malignant melanoma.Cancer Surv. 1995;25:277-92. Cancer Surv. 1995. PMID: 8718523 Review.
Cited by
-
Elevated frequency of an ETS-1 restriction fragment polymorphism in chronic B-cell leukaemia.Hum Genet. 1993 May;91(4):380-2. doi: 10.1007/BF00217361. Hum Genet. 1993. PMID: 8099060
-
Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment.J Cell Biol. 1989 Dec;109(6 Pt 1):3115-28. doi: 10.1083/jcb.109.6.3115. J Cell Biol. 1989. PMID: 2556408 Free PMC article.
-
Allele-specific deletion in exon I of the HRAS1 gene.Am J Hum Genet. 1989 Nov;45(5):689-96. Am J Hum Genet. 1989. PMID: 2573274 Free PMC article.
-
Diagnosis of genetic disease using recombinant DNA. Supplement.Hum Genet. 1987 Sep;77(1):66-75. doi: 10.1007/BF00284717. Hum Genet. 1987. PMID: 3305309 Review.
-
Amplified allele of the human N-myc oncogene in neuroblastomas.Jpn J Cancer Res. 1988 Jun;79(6):670-3. doi: 10.1111/j.1349-7006.1988.tb02219.x. Jpn J Cancer Res. 1988. PMID: 2900826 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials